AQR Arbitrage’s Reviva Pharmaceuticals Warrants RVPHW Stock Holding History

AQR Arbitrage’s Portfolio RVPHW Stock Details RVPHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-32,704	Closed	-$6K	–	1248
2022 Q3	$6K	Sell	32,704 -23,135	-41%	-$5.05K	﹤0.01%	1228
2022 Q2	$10K	Sell	55,839 -47,151	-46%	-$9.53K	﹤0.01%	1224
2022 Q1	$26K	Sell	102,990 -37,472	-27%	-$9.78K	﹤0.01%	1064
2021 Q4	$398K	Sell	140,462 -2,238	-2%	-$890	0.01%	969
2021 Q3	$57K	Sell	142,700 -59,593	-29%	-$25.1K	﹤0.01%	893
2021 Q2	$101K	Sell	202,293 -47,707	-19%	-$21.5K	﹤0.01%	844
2021 Q1	$115K	Hold	250,000	–	–	﹤0.01%	830
2020 Q4	$169K	Hold	250,000	–	–	0.01%	990
2020 Q3	$132K	Hold	250,000	–	–	﹤0.01%	531
2020 Q2	$118K	Hold	250,000	–	–	0.01%	487
2020 Q1	$23K	Hold	250,000	–	–	﹤0.01%	550
2019 Q4	$63K	Hold	250,000	–	–	﹤0.01%	440
2019 Q3	$62K	Hold	250,000	–	–	﹤0.01%	434
2019 Q2	$53K	Hold	250,000	–	–	﹤0.01%	482
2019 Q1	$40K	Hold	250,000	–	–	﹤0.01%	519
2018 Q4	$83K	Buy	+250,000	New	+$80.2K	﹤0.01%	542

Other funds holding RVPHW

Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

NewSquare Capital Newtown Square, Pennsylvania $1.15B AUM 24.78% 1-Year Est. Return

AQR Arbitrage's RVPHW Position: Q4 2022 in Review

AQR Arbitrage sold out of Reviva Pharmaceuticals Warrants (RVPHW) in Q4 2022, closing a stake of 32,704 shares — an estimated $6K sold.

AQR Arbitrage first reported a position in RVPHW in Q4 2018 and held it in 16 quarters. The position peaked at $398K in Q4 2021. 5 funds tracked by Wall St. Rank hold RVPHW as of Q4 2022.

AQR Arbitrage reported no remaining Reviva Pharmaceuticals Warrants position as of Q4 2022 after selling out during the quarter.
AQR Arbitrage sold 32,704 Reviva Pharmaceuticals Warrants shares in Q4 2022, an estimated $6K.
AQR Arbitrage first reported a position in Reviva Pharmaceuticals Warrants in Q4 2018 and held it in 16 quarters.
AQR Arbitrage's Reviva Pharmaceuticals Warrants position peaked at $398K in Q4 2021.
5 funds tracked by Wall St. Rank held Reviva Pharmaceuticals Warrants as of Q4 2022.

Based on AQR Arbitrage's 13F filing for Q4 2022, filed 14 Feb 2023.